Showing results (591-600 of 3,769) with videos related to
Sort By:
Pageof 377
Radiation Oncology (London, England)|November 8, 2017
Multicriteria plan optimization in the hands of physicians: a pilot study in prostate cancer and brain tumorsBirgit S Müller, Helen A Shih, Jason A Efstathiou, et al.Radiation Oncology (London, England)|November 11, 2017
Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancerKonstantina Karava, Stefanie Ehrbar, Oliver Riesterer, et al.Radiation Oncology (London, England)|December 6, 2017
The effect of prone and supine treatment positions for the pre-operative treatment of rectal cancer on organ-at-risk sparing and setup reproducibility using volumetric modulated arc therapyAnthony Kim, Aliaksandr Karotki, Joe Presutti, et al.Radiation Oncology (London, England)|December 9, 2017
Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experiencePippa F Cosper, Jeffrey Olsen, Todd DeWees, et al.Radiation Oncology (London, England)|November 25, 2017
Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old, Salman A Eraj, Mona K Jomaa, et al.Radiation Oncology (London, England)|November 17, 2017
Quality assurance of the SCOPE 1 trial in oesophageal radiotherapyLucy Wills, Rhydian Maggs, Geraint Lewis, et al.Radiation Oncology (London, England)|November 30, 2017
Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumesMacarena Cubillos-Mesías, Michael Baumann, Esther G C Troost, et al.Radiation Oncology (London, England)|October 21, 2017
Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiationMichael C Repka, Nima Aghdam, Shaan K Kataria, et al.Radiation Oncology (London, England)|September 13, 2017
Risk for surgical complications after previous stereotactic body radiotherapy of the spineJohannes Roesch, John B C Cho, Daniel K Fahim, et al.Radiation Oncology (London, England)|July 9, 2016
Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?A D Jensen, M Poulakis, V Vanoni, et al.Pageof 377